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Abstract HslVU is an ATP-dependent protease consisting of
two multimeric components: the HslU ATPase and the HslV
peptidase. SulA, which is an inhibitor of cell division and has high
tendency of aggregation, is degraded by HslVU protease. Here
we show that HslU plays a role not only as a regulatory
component for the HslV-mediated proteolysis but also as a
molecular chaperone. Purified HslU prevented aggregation of
SulA in a concentration-dependent fashion. This chaperone
activity required oligomerization of HslU subunits, which could
be achieved by ATP-binding or in the presence of high HslU
protein concentrations. hsl mutation reduced the SulA-mediated
inhibition of cell growth and this effect could be reversed upon
overproduction of HslU, suggesting that HslU promotes the
ability of SulA to block cell growth through its chaperone
function. Thus, HslU appears to have two antagonistic functions:
one as a chaperone for promotion of the ability of SulA in cell
growth inhibition by preventing SulA aggregation and the other
as the regulatory component for elimination of SulA by
supporting the HslV-mediated degradation. ß 2000 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Chaperones and proteases are expected to share common
characteristics because their substrates are similar, although
they carry out antagonistic reactions. In addition, it has been
implicated that ATP-dependent proteases have intrinsic chap-
erone activity, because initial steps in energy-dependent pro-
tein degradation are similar to those of chaperone-dependent
protein folding. Evidence is accumulating that the ATPase
components of ATP-dependent proteases indeed function as
a molecular chaperone [1,2]. ClpA alone functions as a mo-
lecular chaperone, like DnaK and DnaJ, in the in vitro acti-
vation of the plasmid P1 RepA replication initiator protein by
converting inactive dimers to active monomers [3,4]. ClpA
also functions as a regulatory component for supporting the
proteolytic activity of ClpP, a peptidase that alone can rapidly
cleave small peptides, but absolutely requires ATP hydrolysis
by ClpA for degradation of large polypeptide substrates [5].
Similar to ClpA, ClpX functions as a chaperone in protection
of VO from heat inactivation in vitro [6], disassembly of MuA
transposase^DNA intermediates during the replication and
transposition of bacteriophage Mu DNA [7^9] and activation
of the plasmid RK2 DNA replication initiator protein, TrfA,
by dissociating dimers into monomers [10]. Also, ClpX, as an
alternate regulatory component for ClpP, can support the
degradation of certain regulatory proteins, such as VO protein
[11,12] and the bacteriophage Mu vir repressor [7].
Another Escherichia coli ATP-dependent protease, which
was most recently described, is the HslVU protease consisting
of two heat-shock proteins: a 19-kDa HslV (ClpQ) and a 50-
kDa HslU (ClpY) [13^15]. HslV harbors the peptidase activ-
ity, whereas HslU provides an essential ATPase activity, both
of which can function together as a novel two-component
protease. HslU itself has ATPase activity, markedly stimulates
the proteolytic activity of HslV (more than 20-fold) and tar-
gets large proteins for degradation by HslV, which alone is
unable to degrade proteins. Moreover, it has recently been
shown that in addition to Lon, HslVU participates in the
hydrolysis of SulA in vivo as well as in vitro [16^18].
The SulA protein of E. coli is encoded by the SOS-inducible
sulA gene, which is also called s¢A. The target for SulA is the
essential cell division protein FtsZ, which is a GTPase and
plays a critical role in the initiation of cell division [19^21].
Hydrophobic interactions have been implicated in the com-
plex between FtsZ and SulA [22]. In addition, the SulA pro-
tein is aggregated and precipitated in vivo as well as in vitro
[23,24] and therefore, its puri¢cation in soluble form has been
facilitated by a genetic manipulation to fuse maltose-binding
protein (MBP) to SulA. This tendency of SulA to easily ag-
gregate raised a possibility that its stability requires a chaper-
one function, such as preventing aggregation.
So far, there is no direct evidence for the chaperone func-
tion of HslU, except that HslU is a member of the HSP100/
Clp family [25], most of which are known to function as
chaperones [3,8]. In the present studies, therefore, we exam-
ined whether HslU has a chaperone function in preventing
aggregation of SulA. We also examined the e¡ects of hsl mu-
tation and lon/hsl double mutation on the growth of E. coli
under conditions that SulA was overexpressed, in an attempt
to determine the role of HslU chaperone in regulation of cell
division.
2. Materials and methods
2.1. Bacterial strains and plasmids
MC1000 (wild-type) and its derivative strains, MC1000L (lon: :tet),
MC1000H (hslVU: :kan) and MC1000LH (lon: :tet, hslVU: :kan),
which had been constructed by P1 transduction [17], were used as
hosts for in vivo experiments. pSulA5 containing the wild-type sulA
gene under control of the lacUV5 promoter was transformed into the
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four isogenic strains as described previously [17]. For the expression
of HslU alone, we ¢rst constructed a pACYC vector carrying the lac
promoter followed by a DNA fragment containing a multicloning site.
The EcoRI and HindIII sites in the multicloning site of Bluescript II
SK were eliminated by site-directed mutagenesis. The DNA frag-
ment containing lac promoter and the mutated multicloning site in
the Bluescript vector was cloned by PCR using primers, which had
been designed to carry EcoRI and HindIII sites. The 0.2-kb EcoRI/
HindIII fragment was then ligated into pACUb-M-L-gal [26,27] that
had been treated with the same restriction enzymes, and the resulting
plasmid was referred to as pAC1. To generate a DNA fragment con-
taining only the coding sequence for HslU, PCR was performed using
hslVU operon as template and two primers that had been designed to
carry SacI and KpnI sites. The SacI/KpnI fragment was ligated into
pAC1 that had been treated with the same enzymes. The resulting
plasmid containing the hslU gene under control of the lac promoter
was designated pAC1/HslU. This pAC1/HslU plasmid was trans-
formed into MC1000 and its derivative strains carrying pSulA5 plas-
mid. pET-3Z [28] were transformed into BL21(DE3) cells for over-
production of FtsZ.
2.2. Proteins
Puri¢ed HslV, HslU, HslU/K63T and MBP-SulA were prepared as
described previously [15,17]. FtsZ was puri¢ed from BL21 carrying
pET-3Z as described [29]. Factor Xa (FXa), which can speci¢cally
cleave the linker region between MBP and SulA, was obtained from
New England Biolabs. Protein concentration was determined as de-
scribed [30] using bovine serum albumin as a standard.
2.3. Assay for aggregation of SulA
Reaction mixtures (a ¢nal volume of 0.2 ml) contained 120 Wg
(equivalent to 10 WM) of MBP-SulA, 3 Wg of FXa and increasing
amounts of HslU in 0.1 M Tris^HCl bu¡er (pH 8) containing 10
mM MgCl2, 1 mM EDTA and 1 mM dithiothreitol (DTT). The
samples were incubated for 150 min at 25‡C in the absence or pres-
ence of 4 mM ATP. During the incubation period, aggregation of
SulA was monitored by measuring the apparent absorption due to
scattering at 360 nm with a 10 nm path length in a spectrophotometer.
2.4. Cross-linking analysis
Increasing amounts of HslU were incubated for 20 min at 37‡C in
0.1 M HEPES bu¡er (pH 7.5) containing 10 mM MgCl2, 1 mM
EDTA and 0.4% (v/v) glutaraldehyde in the presence or absence of
1 mM ATP. After incubation, the samples were subjected to SDS^
PAGE on 4^8% gradient slab gels [31]. Proteins in the gels were then
visualized by silver staining.
2.5. Degradation of MBP-SulA and insulin B-chain by HslVU
Incubations were carried out at 37‡C in the reaction mixtures (0.1
ml) containing 0.1 M Tris^HCl (pH 8), 10 mM MgCl2, 1 mM EDTA,
1 mM DTT, 5 Wg MBP-SulA, 0.5 Wg HslV, 2 Wg HslU and increasing
amounts of FtsZ. After incubation, the reaction was stopped by add-
ing 30 Wl of 0.75 M Tris^HCl (pH 6.8) containing 7.5% SDS and 10%
2-mercaptoethanol. They were then subjected to SDS^PAGE on 13%
slab gels [31]. The gels were stained with Coomassie blue R-250. Hy-
drolysis of 125I-labeled insulin B-chain (10 Wg) was assayed by incu-
bating similar reaction mixtures but containing 1 Wg HslV and 4 Wg
HslU for 1 h at 37‡C. After incubation, radioactivity released into
trichloroacetic acid-soluble form (10% ¢nal, w/v) was determined us-
ing a gamma counter.
3. Results
3.1. HslU suppresses aggregation of SulA in vitro
To investigate whether HslU can function as a chaperone
like ClpA and ClpX, puri¢ed HslU was incubated with MBP-
SulA and FXa in the absence or presence of ATP. Since SulA
is known to precipitate when released from MBP-SulA [23]
and since FXa does not cleave HslU (data not shown), the
ability of HslU in prevention of aggregation of SulA could be
monitored by measuring the apparent absorbance due to light
scattering at 360 nm. Remarkably, HslU prevented aggrega-
tion of SulA in a concentration-dependent manner (Fig.
1A,B). Of particular interest was the ¢nding that HslU sup-
pressed aggregation of SulA even in the absence of ATP,
although this e¡ect could markedly be increased by ATP at
low concentrations of HslU (e.g. 0.12 WM). Furthermore,
ATPQS or ADP could also support the ability of HslU in
prevention of SulA aggregation nearly as well as ATP at all
of the HslU concentrations tested (data not shown). On the
other hand, incubation with an excess of other proteins, such
as carbonic anhydrase, showed little or no e¡ect on aggrega-
tion of SulA whether or not ATP was present (Fig. 1B, dotted
line). These results indicate that HslU is capable of preventing
aggregation of SulA and its ATPase activity is not essential
for the chaperone function.
We also examined whether HslU could solubilize previously
formed SulA aggregates. MBP-SulA was treated with FXa for
2 h and then incubated with 2 WM HslU. Under this condi-
tion, the intensity of light scattering remained the same as that
seen without HslU (data not shown). Thus, it appears that
HslU is not capable of solubilizing the already formed aggre-
gates of SulA.
3.2. Requirement of HslU oligomerization for its chaperone
function
Puri¢ed HslU at low concentrations behaves as a monomer
or dimer in the absence of ATP, but forms a hexamer or
heptamer in its presence [32^34]. HslU also behaves as an
oligomer in the presence of ATPQS or ADP, although neither
can support the HslV-mediated degradation of SulA [17].
Therefore, we suspected whether HslU at high concentrations
might be able to form an oligomer even in the absence of ATP
and hence to suppress aggregation of SulA. To test this pos-
sibility, increasing amounts of HslU were subjected to cross-
linking analysis using glutaraldehyde in the absence or pres-
ence of ATP. As shown in Fig. 2A, HslU could form an
oligomer without ATP at high concentrations of the protein
but not at low concentrations. Moreover, the ability of HslU
in preventing aggregation of SulA was closely correlated with
the amount of the HslU oligomer formed in the absence and
presence of ATP (see Figs. 1 and 2). These results strongly
suggest that oligomerization of HslU, but not ATP hydrolysis,
Fig. 1. E¡ects of HslU on aggregation of SulA and cleavage of
MBP-SulA by FXa. MBP-SulA (10 WM) was incubated with FXa
(3 Wg) and increasing concentrations of puri¢ed HslU in the absence
(A) or presence of 1 mM ATP (B) for various periods at 25‡C in a
total volume of 0.2 ml. Light scattering, which is the indicative of
SulA aggregation, was measured as the apparent absorbance at 360
nm. The dotted line indicates carbonic anhydrase (2 WM), which
was added in place of HslU as a control.
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is essential for its chaperone function in prevention of SulA
aggregation.
We have previously shown that a HslU mutant (HslU/
K63T), in which Lys63 was replaced by Thr, is not capable
of binding ATP or forming oligomers [33]. In order to clarify
further whether oligomerization of HslU is essential for its
chaperone function, puri¢ed HslU/K63T was assayed for its
ability to prevent aggregation of SulA by incubation with
MBP-SulA and FXa as above. As shown in Fig. 3A, HslU/
K63T (2 WM), unlike its wild-type protein, could not suppress
SulA aggregation at all. Cross-linking analysis con¢rmed that
HslU/K63T could not oligomerize into either a hexamer or
heptamer, although some intermediate forms, such as dimers,
trimers and tetramers, were generated upon increasing the
concentration of the mutant protein (Fig. 3B). These results
indicate that oligomerization of HslU is essential for its chap-
erone function in prevention of SulA aggregation.
3.3. HslU promotes the SulA-mediated cell growth inhibition
SulA is a cell division inhibitor and its constitutive expres-
sion blocks colony formation of E. coli through binding of
SulA to and subsequent inhibition of the FtsZ GTPase, which
promotes septum formation for cell division [35]. If indeed
HslU functions in vivo as a chaperone in prevention of ag-
gregation of SulA, the cells carrying hsl mutation would pro-
duce a less amount of soluble, functional SulA and hence
could survive better than the wild-type cells under conditions
that SulA is induced for overproduction. To test this possi-
bility, hsl, lon and lon/hsl mutants as well as the wild-type cells
were transformed with pSulA5. They were then grown over-
night on a LB-agar plate streaked with IPTG in the middle.
Fig. 4A shows that the inhibitory e¡ect of SulA on the growth
of hsl mutant cells was signi¢cantly decreased as compared to
that of the wild-type cells. On the other hand, cell growth was
more severely inhibited in lon/hsl double mutant cells than in a
single lon mutant. The HslVU protease has recently been
shown to degrade SulA in vivo as well as in vitro [16^18].
In addition, Lon is known to rapidly degrade SulA under
both conditions [23,36]. Since HslU functions not only as a
chaperone in prevention of SulA aggregation but also as a
Fig. 2. Cross-linking analysis for the concentration-dependent oligo-
merization of HslU. Cross-linking experiments were performed by
incubation of increasing concentrations of HslU with 0.4% glutaral-
dehyde in the absence (A) or presence of 1 mM ATP (B) as de-
scribed under Section 2. The numerals on top of the gels indicate
the concentration of HslU. The arrows indicate heptameric and hex-
americ forms of HslU, and the arrowheads show various intermedi-
ate forms. The asterisk indicates the band corresponding to two
HslU hexamers (or heptamers) cross-linked.
Fig. 3. E¡ect of HslU/K63T, which cannot form oligomer, on SulA
aggregation. MBP-SulA (10 WM) was incubated with FXa (3 Wg) in
the absence (dotted line) or presence of 2 WM HslU/K63T (solid
line) or its wild-type protein (slashed line) for various periods at
25‡C (A). Cross-linking analyses were performed as in Fig. 2 but
with increasing amounts of HslU/K63T (B). The arrows indicate the
positions where the wild-type HslU hexamer or heptamer should
migrate. The arrowhead indicates the HslU/K63T monomer.
Fig. 4. E¡ects of hsl and/or lon mutations on cell growth. The wild-
type cells (wt) and hsl, lon or lon/hsl mutants were transformed with
pSulA5 alone (A). The wild-type cells and hsl null mutant cells car-
rying pSulA5 were also co-transformed with pAC1/HslU or pAC1
(B). They were cross-streaked against 15 Wl of IPTG of the indi-
cated concentrations on LB plates containing 100 Wg/ml ampicillin
or both 100 Wg/ml ampicillin and 34 Wg/ml chloramphenicol for the
cells harboring pAC1/HslU or pAC1. They were then incubated at
37‡C overnight. The numerals shown on the right side of each panel
indicate relative widths of the cleared zone. The width of the cleared
zone seen with the wild-type cells in (A) was expressed as 1.0 and
the others were as its relative values. Similar results were obtained
at at least ¢ve independent trials of the same experiments.
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regulatory component for the degradation of SulA by HslV, it
appears that overproduction of SulA causes more severe in-
hibition of cell growth in the absence of both Lon and HslVU
than in the presence of either of the enzymes.
In order to determine whether the HslU chaperone is in-
deed related to the SulA-mediated cell growth inhibition, the
wild-type cells and hsl mutants were transformed with both
pSulA5 and pAC1/HslU. They were then subjected to the cell
growth inhibition assay as above but at two di¡erent concen-
trations of IPTG. Upon co-transformation of pAC1/HslU,
growth inhibition in hsl mutants increased to a level compa-
rable to that seen in the wild-type cells at each IPTG concen-
tration (Fig. 4B). On the other hand, co-transformation of
pAC1 vector alone showed little or no e¡ect on the growth
of respective cells. These results strongly suggest that HslU is
capable of preventing aggregation of SulA by functioning as a
chaperone in vivo and hence increasing the ability of SulA in
blocking cell division.
3.4. Choice of SulA for interaction with HslU or FtsZ
For cell growth inhibition by SulA, it is essential for the
inhibitory protein to bind to FtsZ. Therefore, SulA bound to
HslU needs to be released from the chaperone for interaction
with FtsZ or directly interact with FtsZ to form a HslU/SulA/
FtsZ ternary complex. To test this possibility, we ¢rst exam-
ined the e¡ect of increasing concentrations of puri¢ed FtsZ on
degradation of MBP-SulA by the HslVU protease. Since FtsZ
has GTPase activity that is essential for Z-ring formation for
promotion of cell division [37], we performed the experiment
in the absence and presence of GTP. As shown in Fig. 5A,
FtsZ inhibited the degradation of MBP-SulA by HslVU in a
concentration-dependent manner whether or not GTP was
present. However, FtsZ at all concentrations showed little
or no e¡ect on the degradation of insulin B-chain by HslVU.
In addition, FtsZ was not hydrolyzed at all by the protease
whether or not GTP was present (data not shown), indicating
that it does not interact with HslU. These results suggest that
SulA has a much higher a⁄nity to FtsZ than to HslU and its
binding site for HslU may be sterically hindered by the tight
interaction between SulA and FtsZ.
SulA is known to inhibit the GTPase activity of FtsZ and
hence block its Z-ring formation [29,35]. In order to determine
whether HslU competes with FtsZ for binding to SulA, we
assayed the ability of SulA to inhibit GTP hydrolysis by FtsZ
in the presence of increasing concentrations of HslU. Little or
no e¡ect of HslU on the inhibitory activity of SulA was evi-
dent at all of the concentrations tested (Fig. 5B). These results
again suggest that SulA has a much higher a⁄nity to FtsZ
than to HslU and therefore can be easily transferred from the
HslU/SulA complex to FtsZ for its inhibitory function on cell
division.
4. Discussion
The present studies have demonstrated that HslU, the ATP-
ase component of the ATP-dependent HslVU protease, has a
chaperone function in prevention of aggregation of SulA, an
inhibitor protein of E. coli cell division. It has recently been
shown that the HslVU protease, in addition to Lon, degrades
the SulA proteins in vivo as well as in vitro [16^18]. Thus, the
HslU ATPase appears to have two antagonistic functions:
one as a chaperone for promotion of the ability of SulA in
cell growth inhibition by preventing SulA aggregation, and
the other as the regulatory component for elimination of
SulA by supporting the HslV-mediated degradation.
Of interest is the ¢nding that under in vitro conditions ATP
itself was not needed for the chaperone activity of HslU as
long as it is kept in oligomeric form, such as in the presence of
ADP or high concentrations of the protein. Moreover, a HslU
mutant (HslU/K63T), which is unable to bind to the adenine
nucleotides or form either hexamer or heptamer due to the
substitution of Lys63 in the consensus ATP-binding motif [33]
by Thr, was not capable of preventing SulA aggregation.
Therefore, oligomerization, but not ATP-binding per se, ap-
pears essential for in vitro interaction of HslU with SulA and
hence for protection of the inhibitor protein from self-aggre-
gation. It has been reported that the chaperone function of
the ClpX ATPase in protecting VO replication activity from
heat inactivation does not require ATP, although it can be
stimulated by the nucleotide [6]. In addition, it has been
shown that a signi¢cant amount of isolated ClpX forms an
oligomer in the absence of ATP, although the nucleotide pro-
motes its oligomerization [38]. However, the ATPase activity
of ClpX as well as of ClpA is essential for their additional,
important chaperone function in disassembly and release of
bound target proteins, such as the Mu transposase and RepA,
respectively [3,9].
It is of note that, unlike for the HslU/SulA complex for-
mation, the binding of HslU with ATP is essential for the
degradation of SulA by HslV, since the ADP-bound form
of HslU cannot interact with HslV [39]. We have recently
demonstrated that ATP hydrolysis is absolutely required for
the degradation of SulA by the HslVU protease [17], but not
Fig. 5. Experimental analysis for comparing the a⁄nity of SulA to
FtsZ with that to HslU. (A) MBP-SulA (5 Wg) was incubated with
HslV (0.5 Wg), HslU (2 Wg) and increasing amounts of FtsZ for 2 h
at 37‡C in the absence (E) or presence (F) of 1 mM GTP, followed
by SDS^PAGE. The gels were stained with Coomassie blue R-250
and the band corresponding to SulA was quanti¢ed using a Phos-
phoimager (Fuji). As a control, 125I-labeled insulin B-chain (10 Wg)
was incubated as substrate in place of MBP-SulA (b). Proteolysis
was then assayed as described in Section 2. The activity of HslVU
seen in the absence of FtsZ was expressed as 100% and the others
were as its relative values. (B) MBP-SulA (15 Wg) was incubated
with increasing amounts of HslU for 10 min at 37‡C in 50 mM
HEPES (pH 7.2) bu¡er containing 50 mM KCl, 10 mM MgCl2,
1 mM ATP and 1 mM DTT. After incubation, the samples were
added with FtsZ (16 Wg) and 1 mM [Q-32P]GTP (0.2 mCi/mmol, 0.2
WCi/ml) and further incubated at 37‡C for 60 min [21]. After incu-
bation, the reaction was terminated and the release of 32Pi was de-
termined as previously described [43]. The activity of FtsZ seen in
the absence of HslU was expressed as 100% and the others were as
its relative values.
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for that of casein, insulin B-chain or N-canbobenzoxy-Gly-
Gly-Leu-7-amide-4-methyl-coumarin. ATPQS, a non-hydro-
lyzable ATP analog, has been shown to support the hydrolysis
of the latter substrates by HslVU even better than ATP, in-
dicating that ATP-binding but not its hydrolysis is required
for the proteolysis [39]. Moreover, a mutant form of HslU
(HslU/C287V), in which Cys287 was replaced by Val and
therefore cannot cleave ATP, could support the HslV-medi-
ated proteolysis of the polypeptides by forming the HslVU
complex in the presence of ATP but not in its absence [40].
In contrast, the degradation of SulA could not at all be seen
upon incubation of HslV with ATP-bound HslU/C287V or
with ATPQS-bound HslU [17]. Furthermore, nucleotide spe-
ci¢city of HslU seems to be strictly limited to ATP, since no
other nucleotide triphosphate (not even dATP) could support
the degradation of SulA by HslVU. Therefore, it appears that
ATP hydrolysis by HslU is required for unfolding of aggre-
gation-prone SulA and subsequent channeling it into the inner
chamber of HslV, where the proteolytic active site is located
[41]. On the other hand, this ATP hydrolysis-dependent chap-
erone function of HslU seems not required for the HslV-medi-
ated degradation of casein, insulin B-chain or small peptides,
which lack appreciable secondary structure. In fact, Lon has
been shown to degrade the unfolded form of CcdA, but not
its native form, without ATP hydrolysis [42].
In summary, we have shown that HslU has a chaperone
function in prevention of aggregation of SulA in vivo as
well as in vitro. We also suggest that HslU, as a component
of HslVU protease, also has ATP hydrolysis-dependent chap-
erone activity in unfolding of SulA for degradation by HslV.
Acknowledgements: We are grateful to Dr. A. Higashitani (National
Institute of Genetics, Japan) for providing pSulA5 and pMAL-p2-
SulA plasmids. This work was supported by the grants from Non-
directed Research Fund from the Korea Ministry of Education, the
Lotte Foundation and CREST, Japan Science and Technology Cor-
poration. J.W.L. was a recipient of the fellowship from BK Program
supported by the Korea Ministry of Education.
References
[1] Gottesman, S., Wickner, S. and Maurizi, M.R. (1997) Genes
Dev. 11, 815^823.
[2] Suzuki, C.K., Sawa, Y., Kaneda, Y., Ichikawa, H., Shirakura, R.
and Matsuda, H. (1997) J. Clin. Invest. 99, 1645^1650.
[3] Wickner, S., Gottesman, S., Skowyra, D., Hoskins, J., McKen-
ney, K. and Maurizi, M.R. (1994) Proc. Natl. Acad. Sci. USA 91,
12218^12222.
[4] Pak, M. and Wickner, S. (1997) Proc. Natl. Acad. Sci. USA 94,
4901^4906.
[5] Woo, K.M., Chung, W.J., Ha, D.B., Goldberg, A.L. and Chung,
C.H. (1989) J. Biol. Chem. 264, 2088^2091.
[6] Wawrzynow, A., Wojtkowiak, D., Marszalek, J., Banecki, B.,
Jonsen, M., Graves, B., Georgopoulos, C. and Zylicz, M.
(1995) EMBO J. 14, 1867^1877.
[7] Mhammedi-Alaoui, A., Pato, M., Gama, M.J. and Toussaint, A.
(1994) Mol. Microbiol. 11, 1109^1116.
[8] Levchenko, I., Luo, L. and Baker, T.A. (1995) Genes Dev. 9,
2399^2408.
[9] Kruklitis, R., Welty, D.J. and Nakai, H. (1996) EMBO J. 15,
935^944.
[10] Konieczny, I. and Helinski, D.R. (1997) Proc. Natl. Acad. Sci.
USA 94, 14378^14382.
[11] Gottesman, S., Clark, W.P., de Crecy-Lagard, V. and Maurizi,
M.R. (1993) J. Biol. Chem. 268, 22618^22626.
[12] Wojtkowiak, D., Georgopoulos, C. and Zylicz, M. (1993) J. Biol.
Chem. 268, 22609^22617.
[13] Missiakas, D., Schwager, F., Betton, J.M., Georgopoulos, C. and
Raina, S. (1996) EMBO J. 15, 6899^6909.
[14] Rohrwild, M., Coux, O., Huang, H.C., Moerschell, R.P., Yoo,
S.J., Seol, J.H., Chung, C.H. and Goldberg, A.L. (1996) Proc.
Natl. Acad. Sci. USA 93, 5808^5813.
[15] Yoo, S.J., Seol, J.H., Shin, D.H., Rohrwild, M., Kang, M.S.,
Tanaka, K., Goldberg, A.L. and Chung, C.H. (1996) J. Biol.
Chem. 271, 14035^14040.
[16] Kanemori, M., Yanagi, H. and Yura, T. (1999) J. Bacteriol. 181,
3674^3680.
[17] Seong, I.S., Oh, J.Y., Yoo, S.J., Seol, J.H. and Chung, C.H.
(1999) FEBS Lett. 456, 211^214.
[18] Wu, W.F., Zhou, Y. and Gottesman, S. (1999) J. Bacteriol. 181,
3681^3687.
[19] Bi, E.F. and Lutkenhaus, J. (1991) Nature 354, 161^164.
[20] de Boer, P., Crossley, R. and Roth¢eld, L. (1992) Nature 359,
254^256.
[21] Mukherjee, A., Dai, K. and Lutkenhaus, J. (1993) Proc. Natl.
Acad. Sci. USA 90, 1053^1057.
[22] Yu, X.C. and Margolin, W. (1998) J. Biol. Chem. 273, 10216^
10222.
[23] Sonezaki, S., Ishii, Y., Okita, K., Sugino, T., Kondo, A. and
Kato, Y. (1995) Appl. Microbiol. Biotechnol. 43, 304^309.
[24] Jubete, Y., Maurizi, M.R. and Gottesman, S. (1996) J. Biol.
Chem. 271, 30798^30803.
[25] Schirmer, E.C., Glover, J.R., Singer, M.A. and Lindquist, S.
(1996) Trends Biochem. Sci. 21, 289^296.
[26] Tobias, J.W. and Varshavsky, A. (1991) J. Biol. Chem. 266,
12021^12028.
[27] Bachmair, A., Finley, D. and Varshavsky, A. (1986) Science 234,
179^186.
[28] RayChaudhuri, D. and Park, J.T. (1992) Nature 359, 251^254.
[29] Mukherjee, A., Cao, C. and Lutkenhaus, J. (1998) Proc. Natl.
Acad. Sci. USA 95, 2885^2890.
[30] Bradford, M.M. (1976) Anal. Biochem. 72, 248^254.
[31] Laemmli, U.K. (1970) Nature 227, 680^685.
[32] Kessel, M., Wu, W., Gottesman, S., Kocsis, E., Stevens, A.C.
and Maurizi, M.R. (1996) FEBS Lett. 398, 274^278.
[33] Shin, D.H., Yoo, S.J., Shim, Y.K., Seol, J.H., Kang, M.S. and
Chung, C.H. (1996) FEBS Lett. 398, 151^154.
[34] Rohrwild, M., Pfeifer, G., Santarius, U., Mu«ller, S.A., Huang,
H.-C., Engel, A., Baumeister, W. and Goldberg, A.L. (1997) Nat.
Struct. Biol. 4, 133^139.
[35] Bi, E. and Lutkenhaus, J. (1993) J. Bacteriol. 175, 1118^1125.
[36] Mizusawa, S. and Gottesman, S. (1983) Proc. Natl. Acad. Sci.
USA 80, 358^362.
[37] Mukherjee, A. and Lutkenhaus, J. (1998) EMBO J. 17, 462^469.
[38] Grimaud, R., Kessel, M., Beuron, F., Steven, A.C. and Maurizi,
M.R. (1998) J. Biol. Chem. 273, 12476^12481.
[39] Yoo, S.J., Seol, J.H., Seong, I.S., Kang, M.S. and Chung, C.H.
(1997) Biochem. Biophys. Res. Commun. 238, 581^585.
[40] Yoo, S.J., Kim, H.H., Shin, D.H., Lee, C.S., Seong, I.S., Seol,
J.H., Shimbara, N., Tanaka, K. and Chung, C.H. (1998) J. Biol.
Chem. 273, 22929^22935.
[41] Bochtler, M., Ditzel, L., Groll, M. and Huber, R. (1997) Proc.
Natl. Acad. Sci. USA 94, 6070^6074.
[42] Melderen, L.V., Thi, M.H.D., Lecchi, P., Gottesman, S., Coutu-
rier, M. and Maurizi, M.R. (1996) J. Biol. Chem. 271, 27730^
27738.
[43] Kim, K.I., Woo, K.M., Seong, I.S., Lee, Z.W., Baek, S.H. and
Chung, C.H. (1998) Biochem. J. 333, 671^676.
FEBS 23927 14-7-00
I.S. Seong et al./FEBS Letters 477 (2000) 224^228228
